Dong-A Socio Holdings Co., Ltd. (KRX:000640)
South Korea
· Delayed Price · Currency is KRW 104,900
-2,000 (-1.87%)
Mar 9, 2026, 3:30 PM KST
Dong-A Socio Holdings Revenue
Dong-A Socio Holdings had revenue of 382.60B KRW in the quarter ending September 30, 2025, with 7.20% growth. This brings the company's revenue in the last twelve months to 1.40T, up 9.02% year-over-year. In the year 2024, Dong-A Socio Holdings had annual revenue of 1.33T with 17.78% growth.
Revenue (ttm)
1,404.83B
Revenue Growth
+9.02%
P/S Ratio
0.48
Revenue / Employee
16.93B
Employees
83
Market Cap
675.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,333.23B | 201.23B | 17.78% |
| Dec 31, 2023 | 1,132.00B | 117.14B | 11.54% |
| Dec 31, 2022 | 1,014.86B | 132.92B | 15.07% |
| Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
| Dec 31, 2020 | 783.32B | 13.63B | 1.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JW Pharmaceutical | 764.21B |
| Boryung | 1,028.99B |
| Huons Global | 825.44B |
| Shinpoong Pharmaceutical Co.,Ltd | 231.90B |
| DongKook Pharmaceutical | 894.93B |
| EuBiologics | 96.04B |
| Daewoong | 2,055.93B |
| Bukwang Pharmaceutical | 184.38B |